scispace - formally typeset
C

Catherine Noguès

Researcher at Aix-Marseille University

Publications -  63
Citations -  4237

Catherine Noguès is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 22, co-authored 63 publications receiving 3235 citations. Previous affiliations of Catherine Noguès include Curie Institute & Paris Descartes University.

Papers
More filters
Journal ArticleDOI

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline Kuchenbaecker, +67 more
- 20 Jun 2017 - 
TL;DR: To estimate age-specific risks of breast, ovarian, and contralateral breast cancer for mutation carriers and to evaluate risk modification by family cancer history and mutation location, a large cohort study recruited in 1997-2011 provides estimates of cancer risk based on BRCA1 and BRCa2 mutation carrier status.
Journal ArticleDOI

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fergus J. Couch, +261 more
- 27 Mar 2013 - 
TL;DR: It is estimated that the breast cancer lifetime risks for the5% of BRCA1 carriers at lowest risk are 28%–50% compared to 81%–100% for the 5% at highest risk, and the ovarian cancer lifetime risk is 63% or higher, based on the known cancer risk-modifying loci.
Journal ArticleDOI

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Timothy R. Rebbeck, +261 more
- 07 Apr 2015 - 
TL;DR: In this paper, the relationship between specific mutations in BRCA1 and cancer risk has been investigated and limited information about the relationship has been available about specific mutations for specific mutations.
Journal ArticleDOI

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours

TL;DR: This work evaluated the correlation of stathmin expression, quantified by reverse transcription polymerase chain reaction, with several disease parameters in a large series of human primary breast cancer, obtained in strictly followed up women, whose clinico-pathological data were fully available.